SGP
SpyGlass Pharma, Inc.
34.97
+0.79 (+2.31%)
52w low 17.06
39.92 high
78.3% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| Return on Equity | -- | -- | 11.3% | 12.7% | -5.5% | -8.5% | |
| Return on Assets | -- | -- | -7.7% | -10.8% | -5.3% | -8.2% | |
| Return on Inv Capital | -- | -- | 12.7% | 13.8% | -6.2% | -9.5% | |
| Liquidity | |||||||
| Current Ratio | -- | -- | 18.11x | 12.67x | 38.00x | 25.06x | |
| Quick Ratio | -- | -- | 18.11x | 12.67x | 38.00x | 25.06x | |
| Cash Ratio | -- | -- | 16.04x | 11.23x | 35.83x | 23.65x | |
| Leverage | |||||||
| Debt / Equity | -- | -- | -0.04x | -0.02x | 0.01x | 0.01x | |
| Equity Multiplier | -- | -- | -1.46x | -1.17x | 1.03x | 1.05x | |
| Efficiency | |||||||
| Asset Turnover | -- | -- | 0.00x | 0.00x | 0.00x | 0.00x | |
| Effective Tax Rate | -- | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | |
| Op CF / Net Income | -- | 0.73x | 0.90x | 0.74x | 0.98x | 0.75x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--